CUE Stock Analysis: Buy, Sell, or Hold?
CUE - Cue Biopharma, Inc.
$28.26
-0.08 (-0.28%)
▼
5d:
+10.65%
30d:
-1.26%
90d:
+13848.67%
BUY
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 11, 2026
Get Alerted When CUE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: CUE shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: CUE shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: CUE is currently trading at $28.26, which is considered fair relative to its 30-day fair value range of $24.15 to $29.75.
Technical Outlook: Technically, CUE is in a strong uptrend. Immediate support is located at $21.84, while resistance sits at $32.60.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $115.00 (+306.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CUE is in a strong uptrend. Immediate support is located at $21.84, while resistance sits at $32.60.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $115.00 (+306.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$24.15 -
$29.75
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.7%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 306.9% below Wall St target ($115.00)
Trading Range Analysis
30-Day Trading Range
$24.15 -
$29.75
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$21.84
Resistance Level
$32.60
Current Trend
Strong Uptrend
Technical data as of
Jun 12, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.99
Wall Street Target
$115.00
(+306.9%)
Revenue Growth (YoY)
1250.6%
Profit Margin
-59.7%
Share & Embed Analysis
Last updated: July 05, 2026 3:13 AM ET
Data refreshes hourly during market hours. Next update: 4:13 AM
Data refreshes hourly during market hours. Next update: 4:13 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CUE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1041 | 62 BUY |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$84 | 63 BUY |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$57 | 51 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$276 | 55 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$83 | 64 BUY |
